Advanced mutant receptor activator of nuclear factor kappa-Β ligand development with low affinity for osteoprotegerin

Yuria Jang; Yongjin Cho; Youngjong Ko; Yeonhee Moon; Chang-Moon Lee; Wonbong Lim

doi:10.1002/ctm2.70195

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (1) : e70195 DOI: 10.1002/ctm2.70195

LETTER TO THE JOURNAL

Advanced mutant receptor activator of nuclear factor kappa-Β ligand development with low affinity for osteoprotegerin

Yuria Jang ¹^,²^,³
, Yongjin Cho ¹^,²
, Youngjong Ko ¹^,²^,³
, Yeonhee Moon ⁴
, Chang-Moon Lee ³^,⁵
, Wonbong Lim ¹^,²^,³^,⁶^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Yuria Jang,Yongjin Cho,Youngjong Ko,Yeonhee Moon,Chang-Moon Lee,Wonbong Lim. Advanced mutant receptor activator of nuclear factor kappa-Β ligand development with low affinity for osteoprotegerin. Clinical and Translational Medicine, 2025, 15(1): e70195 DOI:10.1002/ctm2.70195

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.